The device was returned to the distributor and passed performance testing.Device data logs were provided to resmed for an evaluation.Based on both evaluations, the device was confirmed to have been performing to specification.The autoset cs-a user guide provides the following contraindication: ¿asv therapy is contraindicated in patients with chronic, symptomatic heart failure (nyha 2-4) with reduced left ventricular ejection fraction (lvef <45%) and moderate to severe predominant central sleep apnoea.¿ the user guide also warns that: - ¿patients should report unusual chest pain, severe headache, or increased breathlessness to their prescribing physician.¿ note: further information regarding the trial and remedial action can be found in medwatch 3004604967-2015-00176.In this case, resmed was unable to determine if the desaturation was directly caused by the brief stop in therapy, due to limited information about the patient¿s condition.Resmed reference #: (b)(4).
|